Literature DB >> 29269042

HtrA1 Mediated Intracellular Effects on Tubulin Using a Polarized RPE Disease Model.

Esther Melo1, Philipp Oertle2, Carolyn Trepp3, Hélène Meistermann4, Thomas Burgoyne5, Lorenzo Sborgi2, Alvaro Cortes Cabrera4, Chia-Yi Chen6, Jean-Christophe Hoflack4, Tony Kam-Thong4, Roland Schmucki4, Laura Badi4, Nicholas Flint4, Zeynep Eren Ghiani4, Fréderic Delobel4, Corinne Stucki4, Giulia Gromo4, Alfred Einhaus4, Benoit Hornsperger4, Sabrina Golling4, Juliane Siebourg-Polster4, Francoise Gerber4, Bernd Bohrmann4, Clare Futter5, Tom Dunkley4, Sebastian Hiller2, Oliver Schilling7, Volker Enzmann3, Sascha Fauser4, Marija Plodinec8, Roberto Iacone9.   

Abstract

Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss. The protein HtrA1 is enriched in retinal pigment epithelial (RPE) cells isolated from AMD patients and in drusen deposits. However, it is poorly understood how increased levels of HtrA1 affect the physiological function of the RPE at the intracellular level. Here, we developed hfRPE (human fetal retinal pigment epithelial) cell culture model where cells fully differentiated into a polarized functional monolayer. In this model, we fine-tuned the cellular levels of HtrA1 by targeted overexpression. Our data show that HtrA1 enzymatic activity leads to intracellular degradation of tubulin with a corresponding reduction in the number of microtubules, and consequently to an altered mechanical cell phenotype. HtrA1 overexpression further leads to impaired apical processes and decreased phagocytosis, an essential function for photoreceptor survival. These cellular alterations correlate with the AMD phenotype and thus highlight HtrA1 as an intracellular target for therapeutic interventions towards AMD treatment.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Age-related macular degeneration; Cell stiffness; Disease modelling; HtrA serine peptidase 1; Mechanical properties; Phagocytic activity; Polarized human retinal, pigmented epithelium

Mesh:

Substances:

Year:  2017        PMID: 29269042      PMCID: PMC5828370          DOI: 10.1016/j.ebiom.2017.12.011

Source DB:  PubMed          Journal:  EBioMedicine        ISSN: 2352-3964            Impact factor:   8.143


  5 in total

Review 1.  Asian age-related macular degeneration: from basic science research perspective.

Authors:  Yasuo Yanagi; Valencia Hui Xian Foo; Akitoshi Yoshida
Journal:  Eye (Lond)       Date:  2018-10-12       Impact factor: 3.775

2.  Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy.

Authors:  Irene Tom; Victoria C Pham; Kenneth J Katschke; Wei Li; Wei-Ching Liang; Johnny Gutierrez; Andrew Ah Young; Isabel Figueroa; Shadi Toghi Eshghi; ChingWei V Lee; Jitendra Kanodia; Scott J Snipas; Guy S Salvesen; Phillip Lai; Lee Honigberg; Menno van Lookeren Campagne; Daniel Kirchhofer; Amos Baruch; Jennie R Lill
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-28       Impact factor: 11.205

3.  Cell density-dependent proteolysis by HtrA1 induces translocation of zyxin to the nucleus and increased cell survival.

Authors:  Fabio Sabino; Elizabeta Madzharova; Ulrich Auf dem Keller
Journal:  Cell Death Dis       Date:  2020-08-21       Impact factor: 8.469

4.  HtrA4 Protease Promotes Chemotherapeutic-Dependent Cancer Cell Death.

Authors:  Tomasz Wenta; Michal Rychlowski; Miroslaw Jarzab; Barbara Lipinska
Journal:  Cells       Date:  2019-09-20       Impact factor: 6.600

5.  Late-onset retinal degeneration pathology due to mutations in CTRP5 is mediated through HTRA1.

Authors:  Anil Chekuri; Katarzyna Zientara-Rytter; Angel Soto-Hermida; Shyamanga Borooah; Marina Voronchikhina; Pooja Biswas; Virender Kumar; David Goodsell; Caroline Hayward; Peter Shaw; Chloe Stanton; Donita Garland; Suresh Subramani; Radha Ayyagari
Journal:  Aging Cell       Date:  2019-08-05       Impact factor: 9.304

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.